UAMS Gets Contract to Continue Study of Radiation Treatment Drug

The Biomedical Advanced Research and Development Authority, or BARDA, has exercised two contract options worth about $8.7 million with the University of Arkansas for Medical Sciences to develop a treatment used in radiological or nuclear emergency situations.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.

This is an ad. Please don't block. :)